The INVES BIOFARM team is currently carrying out the VAGINEF project in collaboration with Leitat and the Vall d’Hebron Hospital in Barcelona.
The central goal of the project is the development of an effective and safe topical product designed for the treatment of vaginal atrophy. This development seeks to significantly improve the quality of life for women suffering from this condition.
The crucial technological innovation lies in the use of a protein stabilization technology patented by the company. This method allows the protein activity to be preserved intact for a longer period, thereby ensuring maximum efficacy.
The project benefits from the multidisciplinary expertise of its collaborators:
INVES BIOFARM, Providing the stabilization technology and project coordination.
Leitat, A key technological center and Vall d’Hebron Hospital in Barcelona, Guaranteeing clinical validation and the practical application of the research.